Who is sponsoring NCT03870191?

NCT03870191 is sponsored by Rutgers University.

What drugs are being tested in NCT03870191?

Interventions in NCT03870191: Injection of either twin block or trigger point injection..

What condition does NCT03870191 study?

NCT03870191 studies Myofascial Pain - Dysfunction Syndrome of TMJ, Trigger Point Pain, Myofascial, Nerve Block.

Is NCT03870191 still recruiting?

NCT03870191 is currently completed. Last updated 19 June 2020.

Last reviewed 2020-06-19 · How we verify

NCT03870191

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Therapeutic Effects of Trigger Point Injection and Twin Nerve Block in Chronic Myofascial Pain Patients

Completed NA Last updated 19 June 2020

What this trial tests

NA trial testing Injection of either twin block or trigger point injection. in Myofascial Pain - Dysfunction Syndrome of TMJ in 48 participants. Completed in 31 May 2020.

Timeline

21 June 2016

Primary endpoint
5 June 2018

31 May 2020

Quick facts

Lead sponsor	Rutgers University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	48
Start date	21 June 2016
Primary completion	5 June 2018
Estimated completion	31 May 2020

Drugs / interventions tested

Injection of either twin block or trigger point injection.

Conditions studied

Myofascial Pain - Dysfunction Syndrome of TMJ — all drugs for Myofascial Pain - Dysfunction Syndrome of TMJ →
Trigger Point Pain, Myofascial — all drugs for Trigger Point Pain, Myofascial →
Nerve Block — all drugs for Nerve Block →

Sponsor

Rutgers University

Who can join

Adults 18 to 89, any sex, with Myofascial Pain - Dysfunction Syndrome of TMJ or Trigger Point Pain, Myofascial. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To see if there is there any difference in the treatment outcomes/results such as changes in pain intensity in patients with myofascial pain who have been treated with trigger point injections or twin block?

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The effect of the twin block compared with trigger point injections in patients with masticatory myofascial pain: a pilot study.
Ananthan S, Kanti V, Zagury JG, Quek SYP, et al · · 2020 · cited 5× · PMID 32009005 · DOI 10.1016/j.oooo.2019.09.014

Verify or expand the search:

Other Rutgers University trials

Trials by the same sponsor.

NCT04868123 — Effects of TENS and Mindfulness Meditation in Persons With HIV-related Neuropathy · NA · completed
NCT04563728 — Use Surveillance Technology to Reduce Elder Abuse Recidivism · NA · terminated
NCT04432493 — Using Combined EEG and Non-invasive Brain Stimulation to Examine and Improve Reward Functioning in Opioid Use Disorder · NA · completed
NCT04107688 — Taste Perception, Salivary Proteins & the Oral Microbiome · NA · completed
NCT03672266 — Studies of Brain and Body Interaction · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03870191 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rutgers University
Last refreshed: 19 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03870191.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing